store at low temperature
store at -20°C
Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 478.00 | |
5 mg | In stock | $ 1,390.00 | |
10 mg | In stock | $ 2,280.00 |
Description | Glofitamab (RO7082859) is a novel bivalent antibody directed against CD20-binding T cells.Glofitamab promotes T cell proliferation and activation and tumor cell killing by binding to CD20 on malignant cells.Glofitamab can be used for the palliation of relapsed or refractory B-cell lymphomas. |
Synonyms | RO7082859, RG 6026, CD20-TCB |
Molecular Weight | N/A |
CAS No. | 2229047-91-8 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Glofitamab 2229047-91-8 Others RO7082859 RG 6026 CD20-TCB inhibitor inhibit